206 related articles for article (PubMed ID: 29192263)
1. Comprehensive high-throughput image analysis for therapeutic efficacy of architecturally complex heterotypic organoids.
Bulin AL; Broekgaarden M; Hasan T
Sci Rep; 2017 Nov; 7(1):16645. PubMed ID: 29192263
[TBL] [Abstract][Full Text] [Related]
2. Analysis of Treatment Effects on Structurally Complex Microtumor Cultures Using a Comprehensive Image Analysis Procedure.
Bulin AL; Broekgaarden M; Hasan T
Methods Mol Biol; 2022; 2451():59-70. PubMed ID: 35505010
[TBL] [Abstract][Full Text] [Related]
3. Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.
Praharaj PP; Bhutia SK; Nagrath S; Bitting RL; Deep G
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):117-127. PubMed ID: 29360544
[TBL] [Abstract][Full Text] [Related]
4. Quantitative Phenotypic Image Analysis of Three-Dimensional Organotypic Cultures.
Åkerfelt M; Toriseva M; Nees M
Methods Mol Biol; 2017; 1612():433-445. PubMed ID: 28634961
[TBL] [Abstract][Full Text] [Related]
5. Protocol for generation of and high-throughput drug testing with patient-derived colorectal cancer organoids.
Tan T; Mouradov D; Gibbs P; Sieber OM
STAR Protoc; 2024 Jun; 5(2):103090. PubMed ID: 38809757
[TBL] [Abstract][Full Text] [Related]
6. Metabolic Imaging of Head and Neck Cancer Organoids.
Shah AT; Heaster TM; Skala MC
PLoS One; 2017; 12(1):e0170415. PubMed ID: 28099487
[TBL] [Abstract][Full Text] [Related]
7. Spatiotemporal Tracking of Different Cell Populations in Cancer Organoid Models for Investigations on Photodynamic Therapy.
Bulin AL; Hasan T
Methods Mol Biol; 2022; 2451():81-90. PubMed ID: 35505012
[TBL] [Abstract][Full Text] [Related]
8. High-Throughput Imaging Assay for Drug Screening of 3D Prostate Cancer Organoids.
Choo N; Ramm S; Luu J; Winter JM; Selth LA; Dwyer AR; Frydenberg M; Grummet J; Sandhu S; Hickey TE; Tilley WD; Taylor RA; Risbridger GP; Lawrence MG; Simpson KJ
SLAS Discov; 2021 Oct; 26(9):1107-1124. PubMed ID: 34111999
[TBL] [Abstract][Full Text] [Related]
9. Advanced Development of Primary Pancreatic Organoid Tumor Models for High-Throughput Phenotypic Drug Screening.
Hou S; Tiriac H; Sridharan BP; Scampavia L; Madoux F; Seldin J; Souza GR; Watson D; Tuveson D; Spicer TP
SLAS Discov; 2018 Jul; 23(6):574-584. PubMed ID: 29673279
[TBL] [Abstract][Full Text] [Related]
10. High-content assays for characterizing the viability and morphology of 3D cancer spheroid cultures.
Sirenko O; Mitlo T; Hesley J; Luke S; Owens W; Cromwell EF
Assay Drug Dev Technol; 2015 Sep; 13(7):402-14. PubMed ID: 26317884
[TBL] [Abstract][Full Text] [Related]
11. Organoids as Models for Neoplastic Transformation.
Neal JT; Kuo CJ
Annu Rev Pathol; 2016 May; 11():199-220. PubMed ID: 26907527
[TBL] [Abstract][Full Text] [Related]
12. Morphophenotypic classification of tumor organoids as an indicator of drug exposure and penetration potential.
Karolak A; Poonja S; Rejniak KA
PLoS Comput Biol; 2019 Jul; 15(7):e1007214. PubMed ID: 31310602
[TBL] [Abstract][Full Text] [Related]
13. An Automation Workflow for High-Throughput Manufacturing and Analysis of Scaffold-Supported 3D Tissue Arrays.
Cao R; Li NT; Latour S; Cadavid JL; Tan CM; Forman A; Jackson HW; McGuigan AP
Adv Healthc Mater; 2023 Jul; 12(19):e2202422. PubMed ID: 37086259
[TBL] [Abstract][Full Text] [Related]
14. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
Xie BY; Wu AW
Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of anticancer agents using patient-derived tumor organoids characteristically similar to source tissues.
Tamura H; Higa A; Hoshi H; Hiyama G; Takahashi N; Ryufuku M; Morisawa G; Yanagisawa Y; Ito E; Imai JI; Dobashi Y; Katahira K; Soeda S; Watanabe T; Fujimori K; Watanabe S; Takagi M
Oncol Rep; 2018 Aug; 40(2):635-646. PubMed ID: 29917168
[TBL] [Abstract][Full Text] [Related]
16. A new parameter of growth inhibition for cell proliferation assays.
Fiorentino FP; Bagella L; Marchesi I
J Cell Physiol; 2018 May; 233(5):4106-4115. PubMed ID: 29023715
[TBL] [Abstract][Full Text] [Related]
17. Sample preparation strategies for high-throughput mass spectrometry imaging of primary tumor organoids.
Johnson J; Sharick JT; Skala MC; Li L
J Mass Spectrom; 2020 Apr; 55(4):e4452. PubMed ID: 31661714
[TBL] [Abstract][Full Text] [Related]
18. PREDECT Protocols for Complex 2D/3D Cultures.
Vidic S; Estrada MF; Gjerde K; Santo VE; Osswald A; Barbier M; Chong YT; Sommergruber W; de Hoogt R; Brito C; Graeser R
Methods Mol Biol; 2019; 1888():1-20. PubMed ID: 30519938
[TBL] [Abstract][Full Text] [Related]
19. A one-stop microfluidic-based lung cancer organoid culture platform for testing drug sensitivity.
Jung DJ; Shin TH; Kim M; Sung CO; Jang SJ; Jeong GS
Lab Chip; 2019 Sep; 19(17):2854-2865. PubMed ID: 31367720
[TBL] [Abstract][Full Text] [Related]
20. An Organoid-Based Preclinical Model of Human Gastric Cancer.
Steele NG; Chakrabarti J; Wang J; Biesiada J; Holokai L; Chang J; Nowacki LM; Hawkins J; Mahe M; Sundaram N; Shroyer N; Medvedovic M; Helmrath M; Ahmad S; Zavros Y
Cell Mol Gastroenterol Hepatol; 2019; 7(1):161-184. PubMed ID: 30522949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
